Back
Spyre Therapeutics Stock Price Chart
Sponsored
SYRE
Sponsored
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Sell
19
SYRE
Spyre Therapeutics
Last Price:
$22.45
Seasonality Move:
13.64%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the power of "two-minute trades"
Learn how today!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight selling pressure.
Spyre Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.66 | Sell |
20-day SMA: | 23.91 | Sell |
50-day SMA: | 28.11 | Sell |
200-day SMA: | 30.2 | Sell |
8-day EMA: | 23.67 | Sell |
20-day EMA: | 24.41 | Sell |
50-day EMA: | 26.54 | Sell |
200-day EMA: | 27.83 | Sell |
Spyre Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.08 | Sell |
Relative Strength Index (14 RSI): | 35.95 | Sell |
Chaikin Money Flow: | -139908 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.06 - 25.92) | Sell |
Bollinger Bands (100): | (24.85 - 32.47) | Sell |
Spyre Therapeutics Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spyre Therapeutics Stock
Is Spyre Therapeutics Stock a Buy?
-
Spyre Therapeutics share price is 22.46 while SYRE 8-day simple moving average is 23.66, which is a Sell signal.
-
The stock price of SYRE is 22.46 while Spyre Therapeutics 20-day SMA is 23.91, which makes it a Sell.
-
Spyre Therapeutics 50-day simple moving average is 28.11 while SYRE share price is 22.46, making it a Sell technically.
-
SYRE stock price is 22.46 and Spyre Therapeutics 200-day simple moving average is 30.20, creating a Sell signal.
SYRE Technical Analysis vs Fundamental Analysis
Sell
19
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy or a Sell?
-
Spyre Therapeutics stock is rated a SellThe current Spyre Therapeutics [SYRE] share price is $22.46. The Score for SYRE is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Spyre Therapeutics Stock Info
Market Cap:
1.3B
Price in USD:
22.46
Share Volume:
686.8K
Spyre Therapeutics 52-Week Range
52-Week High:
47.97
52-Week Low:
20.07
Sell
19
Spyre Therapeutics (SYRE)
is a Sell
Spyre Therapeutics Share Price Forecast
-
What is the Spyre Therapeutics stock price today?The Spyre Therapeutics stock price is 22.46 USD today.
-
Will SYRE stock go up or go down?Spyre Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Spyre Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics is overvalued.
Is Spyre Therapeutics Stock a Buy?
-
Spyre Therapeutics share price is 22.46 while SYRE 8-day exponential moving average is 23.67, which is a Sell signal.
-
The stock price of SYRE is 22.46 while Spyre Therapeutics 20-day EMA is 24.41, which makes it a Sell.
-
Spyre Therapeutics 50-day exponential moving average is 26.54 while SYRE share price is 22.46, making it a Sell technically.
-
SYRE stock price is 22.46 and Spyre Therapeutics 200-day simple moving average is 27.83, creating a Sell signal.
Fundamental Analysis of Spyre Therapeutics
Is Spyre Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $1.10 per share.
Technical Analysis of Spyre Therapeutics
Should I short Spyre Therapeutics stock?
-
SYRE Moving Average Covergence Divergence (MACD) indicator is -1.08, suggesting Spyre Therapeutics is a Sell
-
Spyre Therapeutics Relative Strength Index (RSI) is 35.95, which suggest Spyre Therapeutics is oversold
-
The Bollinger Bands (25) for Spyre Therapeutics is (23.06 - 25.92), which suggest Spyre Therapeutics is a Sell
-
The Bollinger Bands (100) for Spyre Therapeutics is (24.85 - 32.47), which suggest Spyre Therapeutics is a Sell
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.